Blue Rock Advisors’s Eli Lilly LLY Stock Holding History

Blue Rock Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,395	Closed	-$6.87M	–	64
2020 Q3	$6.87M	Buy	+46,395	New	+$7.18M	5.93%	3

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Blue Rock Advisors's LLY Position: Q4 2020 in Review

Blue Rock Advisors sold out of Eli Lilly (LLY) in Q4 2020, closing a stake of 46,395 shares — an estimated $6.87M sold.

Blue Rock Advisors first reported a position in LLY in Q3 2020 and held it in 1 quarter. The position peaked at $6.87M in Q3 2020. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

Blue Rock Advisors reported no remaining Eli Lilly position as of Q4 2020 after selling out during the quarter.
Blue Rock Advisors sold 46,395 Eli Lilly shares in Q4 2020, an estimated $6.87M.
Blue Rock Advisors first reported a position in Eli Lilly in Q3 2020 and held it in 1 quarter.
Blue Rock Advisors's Eli Lilly position peaked at $6.87M in Q3 2020.
1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.